Concerning safety and efficacy of concurrent and consolidative durvalumab with thoracic radiotherapy in PDL1-unselected stage III non-small cell lung cancer: brief report
Research output: Contribution to journal › Article › peer-review
Fingerprint
Dive into the research topics of 'Concerning safety and efficacy of concurrent and consolidative durvalumab with thoracic radiotherapy in PDL1-unselected stage III non-small cell lung cancer: brief report'. Together they form a unique fingerprint.